Incyte (INCY) Convertible Debt (2010 - 2020)
Incyte (INCY) reported Convertible Debt of $20.7 million for Q3 2020, up 11.62% quarter-over-quarter from $18.6 million in Q2 2020.
Incyte (INCY) Convertible Debt (2010 - 2020) Analysis & Trends
Incyte has reported Convertible Debt for 11 years, with the latest figure at $20.7 million in Q3 2020.
- For the quarter ending Q3 2020, Convertible Debt changed N/A year-over-year to $20.7 million; the trailing twelve-month figure through Sep 2020 stood at $20.7 million (changed N/A YoY), and the FY2019 full-year result was $32.5 million, up 86.48% from the prior year.
- Convertible Debt for Q3 2020 stood at $20.7 million, up from $18.6 million in the prior quarter.
- The five-year high for Convertible Debt was $651.5 million in Q4 2016, with the low at $16.6 million in Q4 2017.
- Historically, Convertible Debt has averaged $158.8 million across 5 years, with a median of $19.7 million in 2020.
- Annual changes were most pronounced in 2017 — Convertible Debt sank 97.45% — and 2019, when it soared 86.48%.
- Incyte's Convertible Debt stood at $651.5 million in 2016, then slumped by 97.45% to $16.6 million in 2017, then rose by 4.97% to $17.4 million in 2018, then soared by 86.48% to $32.5 million in 2019, then tumbled by 36.18% to $20.7 million in 2020.
- The last three Convertible Debt figures came in at $20.7 million (Q3 2020), $18.6 million (Q2 2020), and $18.5 million (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 20.75 Mn |
| Jun 30, 2020 | 18.59 Mn |
| Mar 31, 2020 | 18.52 Mn |
| Dec 31, 2019 | 32.51 Mn |
| Jun 30, 2019 | 17.86 Mn |
| Mar 31, 2019 | 17.65 Mn |
| Dec 31, 2018 | 17.43 Mn |
| Sep 30, 2018 | 17.22 Mn |
| Jun 30, 2018 | 17.02 Mn |
| Mar 31, 2018 | 16.81 Mn |
| Dec 31, 2017 | 16.61 Mn |
| Sep 30, 2017 | 23.71 Mn |
| Jun 30, 2017 | 23.43 Mn |
| Mar 31, 2017 | 41.60 Mn |
| Dec 31, 2016 | 651.48 Mn |
| Sep 30, 2016 | 643.43 Mn |
| Jun 30, 2016 | 635.49 Mn |
| Mar 31, 2016 | 627.64 Mn |
| Dec 31, 2015 | 619.89 Mn |
| Sep 30, 2015 | 623.93 Mn |